ADIL

ADIAL PHARMACEUTICALS INC

ADIL·00688A304·US·Common Stock-13D/G

ADIL (ADIAL PHARMACEUTICALS INC) is held by 9 institutional investors as of Q2 2026. Largest holders: JANE STREET GROUP, LLC ($82,225), CITADEL ADVISORS LLC ($75,640), UBS Group AG ($49,017). Net institutional sentiment: Mixed.

9
Holders
(1 Elite)
$269,505
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
ADIL

Smart Money Verdict

View all
Loading verdict
Held by 9 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jul 13, 2026 · Activists Jul 1, 2026 · Congress none

InsiderCLCoastlands Capital LPBuy $5KJul 10, 2026
InsiderCLCoastlands Capital LPBuy $28KJul 9, 2026
ActivistCOCoastlands Capital LP14.2%Jul 1, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
32,119$82,2250.0%+118.75%
33
New
29,547$75,6400.0%+118.75%
33
Increased
19,147(+3432.7%)$49,0170.0%+119.40%
22
Decreased
12,393(-48.9%)$31,7250.0%+144.54%
0
Unchanged
5,879$15,0500.0%+144.54%
0
Increased
5,831(+1515.2%)$14,9270.0%+120.19%
20
Decreased
304(-72.6%)$7780.0%+144.54%
0
Unchanged
50$1280.0%+144.54%
0
Unchanged
6$150.0%+144.54%
0
Exited
0(-100.0%)$70.0%+11.79%
0
ADILADILADIAL PHARMACEUTICALS INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used